Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
FFuso Pharmaceutical Industries,Ltd. logo
4538TSE Prime

Fuso Pharmaceutical Industries,Ltd.

扶桑薬品工業 Yahoo Finance

Recent & upcoming events

Aug 10
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 23
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 12
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Nov 11
Earnings 1:00 approx.
Q2 earnings announcement (scheduled)
Add to Google Calendar
2027
Feb 10
Earnings 1:00 approx.
Q3 earnings announcement (scheduled)
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
May 12
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Aug 11
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥62.31B YoY +2.9%
Operating income ¥2.64B margin 4.2%
Net income ¥2.01B YoY —
EPS —
P/E —
ROE —

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥63.20B +1.4%
Operating income ¥2.00B -24.2%
Net income ¥1.30B -35.4%
EPS ¥152 —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY25 Q2
Revenue ¥11.80B¥13.51B¥13.92B¥15.41B¥12.58B—
Operating income ¥241M¥590M¥509M¥744M¥121M—
Net income ¥112M¥479M¥238M¥510M¥150M—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 8.6%国内機関 14.6%個人 5.9%その他 7%未開示 63.9%202120222023202420252026
事業法人国内機関個人その他未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

ぶどう協和会 7%ぶどう協和会日本マスタートラスト信託銀行株式会社 6.6%日本マスタートラスト信託銀行株式会社（信託口）敷島振興株式会社 5.3%敷島振興株式会社扶桑薬品工業従業員持株会 3.8%扶桑薬品工業従業員持株会株式会社三井住友銀行 3.3%株式会社三井住友銀行三井住友信託銀行株式会社 2.9%三井住友信託銀行株式会社戸　田　幹　雄 2.1%戸　田　幹　雄日本生命保険相互会社 1.9%日本生命保険相互会社中尾薬品株式会社 1.8%中尾薬品株式会社内外化成株式会社 1.5%内外化成株式会社202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
ぶどう協和会 599,000 7.0% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社（信託口） 563,000 6.6% Yuho (EDINET)
敷島振興株式会社 452,000 5.3% Yuho (EDINET)
扶桑薬品工業従業員持株会 327,000 3.8% Yuho (EDINET)
株式会社三井住友銀行 278,000 3.3% Yuho (EDINET)
三井住友信託銀行株式会社 245,000 2.9% Yuho (EDINET)
戸 田 幹 雄 179,000 2.1% Yuho (EDINET)
日本生命保険相互会社 159,000 1.9% Yuho (EDINET)
中尾薬品株式会社 151,000 1.8% Yuho (EDINET)
内外化成株式会社 127,000 1.5% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

3/9 4 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 2.2%
— Positive operating cash flow No data
✓ ROA improved YoY -4.0% → 2.2%
— Operating CF exceeds net income (accrual quality) No data
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 40.4% → 38.8%
— Current ratio improved No data
✓ No dilution (shares outstanding did not increase) 9,451,169 → 9,451,169
— Gross margin improved No data
✗ Asset turnover improved 0.74× → 0.69×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio —
Current ratio —
Years of positive operating CF 4 of last 6 yrs
Payout ratio 38%
Latest fiscal year result Profit (net income ¥2.01B)

Performance history

Last 10 years
0億円156億円312億円467億円623億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 468459461469493496510554606623
Operating income 6.567.9812.610.123.519.222.119.641.326.4
Ordinary income 6.428.3212.810.722.320.022.218.737.823.5
Net income 8.619.708.947.0716.114.816.113.8-32.920.1
Total assets 688702717692699693725758817903
Equity 325326328323337345356367330351

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ———¥81¥183¥169¥183¥160¥-385—
ROE ——————————
Operating CF ———34.116.213.4-6.30-26.828.8—
Investing CF ———-15.9-9.95-15.8-13.5-31.9-21.9—
Financing CF ———-18.0-24.4-16.7-8.130.1476.2—
FCF ———32.220.220.112.8-29.6-64.0—

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data